NCT00209430View on ClinicalTrials.gov

Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Coronary Angiography

PHASE4CompletedINTERVENTIONAL
Enrollment

408

Participants

Timeline

Start Date

August 31, 2005

Conditions
Coronary Artery DiseaseRenal Impairment
Interventions
DRUG

Iodixanol 320 mgI/mL

Trial Locations (1)

Unknown

Amersham Health S.A, Solna

Sponsors

Lead Sponsor

GE Healthcare
All Listed Sponsors
lead

GE Healthcare

INDUSTRY